Filters
Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.
Singapore’s Ministry of Health (MOH) has confirmed 876 new cases of COVID-19 infection on May 10. Two casualties have been recorded on May 6, bringing the total COVID-19 deaths in the city-state to 20. Older age seems a common factor among them.
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Use of the interleukin(IL)-1 inhibitor anakinra led to clinical improvements in patients with coronavirus disease (COVID)-19, acute respiratory distress syndrome (ARDS), and systemic inflammation who are under noninvasive ventilation outside the intensive care unit (ICU), an Italian retrospective study has shown.
Patients with advanced non-small-cell lung cancer (NSCLC) who have a past medical history of pneumonitis are at increased risk of treatment-related pneumonitis (TAP) from immune checkpoint inhibitor (ICI) regimens or chemotherapy alone, an analysis of clinical trial and real-world data has shown.
Living alone and social disengagement may increase the risk of hospital admission for respiratory disease in older adults, a recent study has shown.
Treatment with baricitinib led to clinically meaningful improvements in itch and skin symptoms in patients with moderate-to-severe atopic dermatitis (AD), even in those with additional comorbid atopic conditions, according to a pooled analysis of two phase III studies released in the AAAAI 2020 Meeting.
At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).
In infants born extremely premature, immunization with palivizumab does not confer apparent protective effects on respiratory symptoms and pulmonary function at adolescence, as reported in a recent study. Nevertheless, immunized survivors of extreme prematurity show good clinical and physiological outcomes.
Both alcohol-based hand rub formulations recommended by the WHO* are effective against SARS-Cov-2 when used correctly, a new study shows — supporting their use in healthcare settings and viral outbreaks.
